Osanni Bio

Private

#Ophthalmology #Cardiology #Cardiovascular Disease

Osanni Bio is a San Francisco-based biotechnology company building a pipeline of therapeutics for ophthalmology and cardiology indications. The company raised $190M in 2026 to advance its portfolio of small-molecule and biologic candidates addressing high-prevalence vision and cardiovascular diseases.

Company Info

Sector:Biotechnology / Ophthalmology / Cardiology

Headquarters:San Francisco, California, USA

Founded:2023

Website:osanni.bio/

Clinical Development Pipeline

Undisclosed

Target: TBD

Ophthalmology / cardiology

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Osanni Bio gets $190M to build ophthalmology and cardiology pipeline ↗

San Francisco biotech Osanni Bio, looking to build out a suite of ophthalmology- and cardiology-focused

Leadership Team

D. Michael Ackermann, Ph.D.

Founder and Chief Executive Officer

Careers & Job Openings

See all open roles

Multiple Departments

See careers page

Apply Now →